Saku Biosciences is an early stage life sciences company that aims to reduce the costs to make biotechnology products. We accomplish this by using directed cellular evolution using our groundbreaking PicoShell technology, a lab-on-a-particle technology that is the first high-throughput screening tool designed to increase yields.
Saku Biosciences serves customers by offering contract services and cell/strain products that can can directly integrate into cell line developer and strain engineer workflows.
By reducing the costs to make bioproducts, we will significantly broaden the impact of the biotechnology industry.
Company Details
- Employees
- 5
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Saku Biosciences Questions
Saku Biosciences's LinkedIn profile is https://www.linkedin.com/company/saku-biosciences
Saku Biosciences has
5 employees.
View email and phone details for 5
employees at Saku Biosciences.
Saku Biosciences's industry is
Biotechnology Research
Saku Biosciences's top competitors are
Osem Fluidics,
Tempo Therapeutics,
Blue-X Ventures,
Entropic Biosciences, Inc.,
Metaba,
Forcyte Biotechnologies, Inc,
Vortex Liquid Biopsy Solutions,
Cue Health,
Partillion Bioscience,
Cytovale.
Saku Biosciences's categories are Biotechnology Research
Saku Biosciences's founding year is 2024
